MAP2K2 (MEK2 ) mouse monoclonal antibody, clone OTI5B4 (formerly 5B4)
| Applications | IF, WB |
| Reactivities | Human, Dog, Mouse, Rat |
Products
Transient overexpression lysate of mitogen-activated protein kinase kinase 2 (MAP2K2)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression of MAP2K2 in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
MAP2K2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
Anti-MAP2K2 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Anti-MAP2K2 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Goat Anti-MAP2K2 / MEK2 Antibody
| Applications | WB |
| Reactivities | Human |
Rabbit Polyclonal MEK2 (Thr394) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Modifications | Phospho-specific |
Rabbit Polyclonal MEK2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Rabbit anti Mek2 Polyclonal Antibody
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) MAP2K2 mouse monoclonal antibody, clone OTI5G8 (formerly 5G8)
| Applications | IF, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K2 (tGFP-tagged) - Human mitogen-activated protein kinase kinase 2 (MAP2K2)
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
MAP2K2 Mutant (F57V), Myc-DDK-tagged ORF clone of Homo sapiens mitogen-activated protein kinase kinase 2 (MAP2K2) as transfection-ready DNA
| Mutation | F57V |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Reporters
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Brands
QC Levels
Pathways
- Acute myeloid leukemia (60)
- B cell receptor signaling pathway (60)
- Bladder cancer (60)
- Chronic myeloid leukemia (60)
- Endometrial cancer (60)
- ErbB signaling pathway (60)
- Fc epsilon RI signaling pathway (60)
- Gap junction (60)
- Glioma (60)
- GnRH signaling pathway (60)
- Insulin signaling pathway (60)
- Long-term depression (60)
- Long-term potentiation (60)
- MAPK signaling pathway (60)
- Melanogenesis (60)
- Melanoma (60)
- Natural killer cell mediated cytotoxicity (60)
- Neurotrophin signaling pathway (60)
- Non-small cell lung cancer (60)
- Pathways in cancer (60)
- Prion diseases (60)
- Prostate cancer (60)
- Regulation of actin cytoskeleton (60)
- Renal cell carcinoma (60)
- T cell receptor signaling pathway (60)
- Thyroid cancer (60)
- Toll-like receptor signaling pathway (60)
- VEGF signaling pathway (60)
- Vascular smooth muscle contraction (60)
